Article Details
Retrieved on: 2018-10-11 00:46:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Sofinnova Ventures</b> Inc bought a new stake in Syndax Pharmaceuticals in the first quarter worth approximately $173,000. Rhumbline Advisers bought ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here